The Global Genitourinary Robotic Surgery Market is estimated to exhibit a CAGR of 12.3% during the forecast period. 

Request for Sample Pages:

Robotic surgery is a minimally invasive surgery that employs robotic technology to carry out surgical procedures. These automated devices are controlled by surgeons and feature miniature surgical tools that are attached to robotic arms, enabling surgeons to perform surgery precisely. Laparoscopic or minimally invasive surgery (MIS) is becoming more and more popular due to its advantages for both patients and surgeons, including improved screening, increased precision, shorter hospital stays, decreased pain and discomfort, decreased risk of infection, and decreased blood flow and transfusion. Additionally, the market for surgical robots is expanding as a result of the rise in gynaecological and urological conditions. The development of novel, advanced robots will satisfy the expanding demands of end-users. The expanding requirement for automation in the healthcare sector and the changing trend toward sophisticated robotic surgery are the main drivers driving the market size for surgical robots. The market is expected to develop as a result of an increase in the number of robotic surgical systems as well as ongoing manufacturer R&D and investment in automated robotic systems.

List of Prominent Players in the Genitourinary Robotic Surgery Market:

AVRA Medical Robotics, Inc.,


Simbionix USA Corporation,

Renishaw plc,

THINK Surgical, Inc,

TransEnterix Surgical, Inc.,

Titan Medical Inc.,


Intuitive Surgical,

Medrobotics Corporation,

Blue Belt Technologies Ltd.,

MAKO Surgical Corp.,

Mazor Robotics Ltd.,

Stanmore Implants Worldwide, Ltd.,

Hansen Medical, Inc.,

SafeStitch Medical In

Curious about this latest version of the report?  Obtain Report Details @

Market Dynamics:


The advantages connected with these treatments, such as smaller incisions, fewer cuts, decreased scarring, reduced discomfort, increased safety, quicker recovery times, and significant cost savings, are driving up demand for minimally invasive surgeries (MIS) globally. These benefits are enhanced by robotic minimally invasive surgery, which provides improved accuracy, repeatability, control, and efficiency. The fast adoption of a sedentary lifestyle and the rise in the number of senior patients with chronic diseases are two important contributing factors to age- and lifestyle-related chronic disorders. The need for robotic surgical techniques for urgent care is consequently rising. Healthcare practitioners are increasingly turning to robot-assisted surgery for various purposes due to the development of such cutting-edge and novel technology systems and advantageous reimbursement schemes for surgeries performed with surgical robots globally.


Costs for acquisition and maintenance are more significant for robotic surgical equipment. The higher cost of consumables per procedure for robotic systems is the leading cause of the relatively higher pricing of these treatments. As a result, the factors holding back the expansion of the global market are the high cost of the robotic system and the correspondingly higher costs of its maintenance. One of the main risk factors is mechanical failure. Even while malfunctions are quite unlikely, they shouldn’t ever be disregarded. In some situations, it may result in nerve damage and possible lesions, wounds, or rips to the surrounding organs. Similar to the lack of experience, robotic surgery has many drawbacks.

Regional Trend:

During the forecast period, North America will hold the major share of the market. The regional market is being driven by the expansion of next-generation healthcare facilities in the U.S. and the rising use of automated surgical tools. Additionally, the U.S. patient population’s dearth of doctors and surgeons is anticipated to fuel regional market growth. The market in the United States is anticipated to expand over the following years as a result of the significant rise in the incidence and prevalence of renal disorders. The region’s market expansion is expected to be boosted by rising modern healthcare facilities and growing awareness of the benefits of adopting innovative medical technologies. The ever-increasing government attempts to create cutting-edge healthcare infrastructure draw international investors to participate in the development of automated instruments, which is predicted to drive market expansion in this area over the upcoming years.

Recent Developments:

  • In June 2020, Accuray Incorporated (NASDAQ: ARAY) announced the company had introduced the CyberKnife S7TM System, a breakthrough tool combining speed, improved precision, and real-time artificial intelligence (AI) driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments in as little as 15 minutes.
  • In February 2020, Medtronic plc announced the purchase of Digital Surgery, a privately held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. The acquisition of Digital Surgery will enhance Medtronic’s robotic-assisted surgery platform and be applicable to the company’s more comprehensive range of products. No details of the arrangement are being made public.

Segmentation of Genitourinary Robotic Surgery Market-

By Component

  • Robotic Surgery Machine
  • Tracking/ Navigation System
  • Stimulators & Planners
  • Others

By Product Type

  • Robotic Surgery Instrument
  • Accessories
  • Services

By Application

  • Robotic Prostatectomy
  • Robotic Cystectomy
  • Robotic Pyeloplasty
  • Robotic Nephrectomy
  • Others

By End-User

  • Hospitals
  • Urology Clinics
  • Research & Education Center

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Information @

Tags: Global Genitourinary Robotic Surgery Market